Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2025-12-25 @ 10:44 PM
NCT ID: NCT00837967
Description: Of 25 patients in safety analysis set, 2 patients did not receive terbutaline due to adverse events lead to discontinuation. Therefore, data from 25 patients for Symbicort and 23 patients for terbutaline were used for the safety evaluation.
Frequency Threshold: 5
Time Frame: None
Study: NCT00837967
Study Brief: Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Symbicort Symbicort Turbuhaler 160/4.5μg for 3 days None None 0 25 7 25 View
Terbutaline Terbutaline Turbuhaler 0.4 mg for 3 days None None 0 23 15 23 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 12.0 View
Tremor SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (12.0) View
Palpitations SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (12.0) View
Tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (12.0) View
Blood Pressure Decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA (12.0) View